{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:41:34Z","timestamp":1787312494435,"version":"build-2736575974"},"reference-count":54,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>In the clinical context of the new medical concept of diseases related to the Major Histocompatibility Complex class I (MHC-I-opathy), contrasting data are available on the possible association among HLA-B*51, Behcet\u2019s disease (BD), and spondyloarthritis (SpA). The aim of this retrospective study on a cohort of HLA-B*51-positive patients who were clinically observed for almost 5 years is primarily to evaluate which classification criteria they satisfy among BD, axial (ax) or peripheral (p) SpA, and psoriatic arthritis (PsA). Furthermore, we characterized the possible impact of different arthritis phenotypes on the most frequent extra-articular clinical manifestations in BD, ax-SpA, p-SpA, and PsA. A comparison with HLA-B*51-negative patients (matched with HLA-B*51-positive patients for age, gender, and diagnosis, by mean propensity score) was also performed to evaluate the true impact on clinical manifestations of HLA-B*51. We conducted a monocentric retrospective study from 2013 to 2025. The inclusion criteria were HLA-B*51 positivity, the availability of the entire MHC-I class test, and rheumatological clinical follow-up of at least 5 years. The exclusion criterion was positivity for clinically important MCH-I loci other than HLA-B*51. A total of 105 patients met the inclusion criteria in an average clinical observation period of 8.4 \u00b1 2.9 years. All patients were Apulian and were HLA-B* 51 positive. During the follow-up, 32 patients (31%) met the BD criteria, 17 (16%) met the PsA criteria, 25 (24%) met the p-SpA criteria, and 13 (12%) met the ax-SpA criteria. Of note, 16% and 34% of BD patients met the ax-SpA and p-SpA ASAS criteria, respectively. Prevalent articular phenotypes in this HLA-B*51 cluster of patients are a polyarticular pattern and enthesis involvement in all disease groups. In BD patients, axial involvement was associated with a significantly higher percentage of neurological manifestations (40% vs. 7%, p = 0.043) and inflammatory bowel disease (IBD) (100% vs. 15%, p = 0.0001), compared to patients with exclusive peripheral joint involvement. This latest data on IBD remains significant, even in comparison with HLA-B*51 negative patients (33%; p = 0.035). In the p-SpA group, a significantly higher rate of uveitis (28%) was observed compared to both ax-SpA with HLA-B*51-positive (0%, p = 0.035) and p-SpA with HLA-B*51-negative patients (4%, p = 0.030). A high percentage of multi-drug failures was highlighted in patients with PsA (60%) and p-SpA (40%). This study provides new data on the association between HLA-B*51 and the onset of BD and\/or SpA or PsA, and its possible impact on extra-articular manifestations. We confirm the higher prevalence of the peripheral articular phenotype in BD, but we also highlight a specific association between the rarer axial involvement and gastrointestinal involvement in HLA-B*51 patients. In SpA, the peripheral articular phenotype appears to be associated with a higher occurrence of uveitis in the presence of HLA-B*51.<\/jats:p>","DOI":"10.3390\/ijms27093721","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T12:54:08Z","timestamp":1776862448000},"page":"3721","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["HLA-B*51 Beyond Behcet\u2019s Disease: Topography of Symptoms, Associated Diagnoses, and Characterization of Chronic Inflammatory Arthritis Phenotypes"],"prefix":"10.3390","volume":"27","author":[{"given":"Cinzia","family":"Rotondo","sequence":"first","affiliation":[{"name":"Rheumatology Unit, Department of Medical and Surgical Sciences, Azienda Ospedaliero-Universitaria Policlinico Riuniti di Foggia, Universit\u00e0 degli Studi di Foggia, 71122 Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6412-2256","authenticated-orcid":false,"given":"Giuseppe","family":"Busto","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medical and Surgical Sciences, Azienda Ospedaliero-Universitaria Policlinico Riuniti di Foggia, Universit\u00e0 degli Studi di Foggia, 71122 Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1081-7928","authenticated-orcid":false,"given":"Raffaele","family":"Barile","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medical and Surgical Sciences, Azienda Ospedaliero-Universitaria Policlinico Riuniti di Foggia, Universit\u00e0 degli Studi di Foggia, 71122 Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3750-5934","authenticated-orcid":false,"given":"Giulio","family":"Giancaspro","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medical and Surgical Sciences, Azienda Ospedaliero-Universitaria Policlinico Riuniti di Foggia, Universit\u00e0 degli Studi di Foggia, 71122 Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brunella","family":"Capuano","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medical and Surgical Sciences, Azienda Ospedaliero-Universitaria Policlinico Riuniti di Foggia, Universit\u00e0 degli Studi di Foggia, 71122 Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6708-9105","authenticated-orcid":false,"given":"Valeria","family":"Rella","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medical and Surgical Sciences, Azienda Ospedaliero-Universitaria Policlinico Riuniti di Foggia, Universit\u00e0 degli Studi di Foggia, 71122 Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9929-9177","authenticated-orcid":false,"given":"Francesco Paolo","family":"Cantatore","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medical and Surgical Sciences, Azienda Ospedaliero-Universitaria Policlinico Riuniti di Foggia, Universit\u00e0 degli Studi di Foggia, 71122 Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Addolorata","family":"Corrado","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medical and Surgical Sciences, Azienda Ospedaliero-Universitaria Policlinico Riuniti di Foggia, Universit\u00e0 degli Studi di Foggia, 71122 Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"McGonagle, D., and McDermott, M.F. (2006). A proposed classification of the immunological diseases. PLoS Med., 3.","DOI":"10.1371\/journal.pmed.0030297"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ng.2520","article-title":"Genome-wide association analysis identifies new susceptibility loci for Beh\u00e7et\u2019s disease and epistasis between HLA-B*51 and ERAP1","volume":"45","author":"Kirino","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/ng.3786","article-title":"Dense genotyping of immune-related loci implicates host responses to microbial ex-posure in Beh\u00e7et\u2019s disease susceptibility","volume":"49","author":"Takeuchi","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ng.694","article-title":"A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1","volume":"42","author":"Strange","year":"2010","journal-title":"Nat. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1136\/annrheumdis-2017-211414","article-title":"Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis","volume":"76","author":"Bowes","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.ajhg.2015.10.019","article-title":"Genome-wide association analysis of psoriatic arthritis and cutaneous psoriasis reveals differences in their genetic architecture","volume":"97","author":"Stuart","year":"2015","journal-title":"Am. J. Hum. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ng.873","article-title":"Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility","volume":"43","author":"Evans","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/iovs.61.6.3","article-title":"Genome-wide association study of acute anterior uveitis identifies new susceptibility loci","volume":"61","author":"Huang","year":"2020","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.1093\/hmg\/ddu307","article-title":"A genome-wide association study identifies a functional ERAP2 haplotype associated with birdshot chorioretinopathy","volume":"23","author":"Kuiper","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/iovs.62.14.3","article-title":"ERAP1, ERAP2, and two copies of HLA-aw19 alleles increase the risk for birdshot chorioretinopathy in HLA-A29 carriers","volume":"62","author":"Gelfman","year":"2021","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-immunol-032414-112110","article-title":"HLA-B27","volume":"33","author":"Bowness","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.molimm.2013.07.013","article-title":"HLA-B27 misfolding and ankylosing spondylitis","volume":"57","author":"Colbert","year":"2014","journal-title":"Mol. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/cei.13049","article-title":"Is Beh\u00e7et\u2019s disease a \u2018class 1-opathy\u2019? The role of HLA-B*51 in the pathogenesis of Beh\u00e7et\u2019s disease","volume":"191","author":"Giza","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1136\/ard-2022-222852","article-title":"EULAR study group on \u2018MHC-I-opathy\u2019: Identifying disease-overarching mechanisms across disciplines and borders","volume":"82","author":"Kuiper","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s12026-022-09298-5","article-title":"Effect of different cytokines in combination with IL-15 on the expression of activating receptors in NK cells of patients with Beh\u00e7et\u2019s disease","volume":"70","author":"Sallakci","year":"2022","journal-title":"Immunol. Res."},{"key":"ref_16","first-page":"49","article-title":"The roles of immune cells in Behcet\u2019s disease","volume":"63","author":"Hu","year":"2023","journal-title":"Hortic. Bras."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41435-022-00168-6","article-title":"Progress in the genetics of uveitis","volume":"23","author":"Huang","year":"2022","journal-title":"Genes Immun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/art.1780380321","article-title":"Excessive function of peripheral blood neutrophils from patients with Behcet\u2019s disease and from HLA-B51 transgenic mice","volume":"38","author":"Takeno","year":"1995","journal-title":"Arthritis Rheum."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/08830189709116841","article-title":"Hyperreactivity of neutrophils and abnormal T cell homeostasis: A new insight for pathogenesis of Behcet\u2019s disease","volume":"14","author":"Yamashita","year":"1997","journal-title":"Int. Rev. Immunol."},{"key":"ref_20","first-page":"S51","article-title":"Genetics of Beh\u00e7et\u2019s disease in Sardinia: Two distinct extended HLA haplotypes harbour the B51 allele in the normal population and in patients","volume":"30","author":"Piga","year":"2012","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_21","first-page":"1699","article-title":"Beh\u00e7et\u2019s syndrome: One year in review 2025","volume":"43","author":"Hatemi","year":"2025","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"rkad087","DOI":"10.1093\/rap\/rkad087","article-title":"The relationship between HLA-B*51 subtypes, clinical manifestations and severity of Beh\u00e7et\u2019s syndrome: A large Italian cohort study","volume":"7","author":"Leccese","year":"2023","journal-title":"Rheumatol. Adv. Pract."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Khoshbakht, S., Ba\u015fkurt, D., Vural, A., and Vural, S. (2023). Beh\u00e7et\u2019s Disease: A Comprehensive Review on the Role of HLA-B*51, Antigen Presentation, and Inflammatory Cascade. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242216382"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/rheumatology\/ker428","article-title":"Relationships of HLA-B51 or B5 genotype with Behcet\u2019s disease clinical characteristics: Systematic review and meta-analyses of observational studies","volume":"51","author":"Maldini","year":"2012","journal-title":"Rheumatology"},{"key":"ref_25","first-page":"653806","article-title":"Musculoskeletal Findings in Behcet\u2032s Disease","volume":"2012","author":"Bicer","year":"2011","journal-title":"Pathol. Res. Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/mr\/roaf049","article-title":"The trends in the prevalence of arthritis and arthralgia and their associations with extra-articular manifestations in patients with Behcet\u2019s disease: A systematic review and meta-analysis","volume":"35","author":"Mohamadi","year":"2025","journal-title":"Mod. Rheumatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/rheumatology\/keae366","article-title":"HLA-B5 prevalence in patients with spondyloarthritis and impact on disease phenotype: A multicentric case\u2013control study","volume":"64","author":"Ziade","year":"2024","journal-title":"Rheumatology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"8422","DOI":"10.12998\/wjcc.v10.i23.8422","article-title":"Reflections on the prevalence of human leukocyte antigen-B27 and human leukocyte antigen-B51 co-occurrence in patients with spondylarthritis World J Clin Cases","volume":"10","author":"Shinjo","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1038\/s41598-021-81972-4","article-title":"Association of Beh\u00e7et disease with psoriasis and psoriatic arthritis","volume":"11","author":"Hahn","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2015.147","article-title":"MHC-I-opathy\u2019-unified concept for spondyloarthritis and Beh\u00e7et disease","volume":"11","author":"McGonagle","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.21926\/obm.genet.2403261","article-title":"Clinical features, genetic landscape, and management of Beh\u00e7et\u2019s syndrome: A comprehensive review","volume":"8","author":"Masiello","year":"2024","journal-title":"OBM Genet."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"110549","DOI":"10.1016\/j.clim.2025.110549","article-title":"Etiopathogenesis of Beh\u00e7et\u2019s disease: A systematic literature review","volume":"279","author":"Choukri","year":"2025","journal-title":"Clin. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Leccese, P., and Alpsoy, E. (2019). Beh\u00e7et\u2019s disease: An overview of etiopathogenesis. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01067"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1034\/j.1399-0039.1999.540605.x","article-title":"Significant associations of HLAB5101 and B5108, and lack of association of class II alleles with Behcet\u2019s disease in Italian patients","volume":"54","author":"Kera","year":"1999","journal-title":"Tissue Antigens"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00005792-197409000-00002","article-title":"Associations between ankylosing spondylitis, psoriatic arthritis, Reiter\u2019s disease, the intestinal arthropathies and Beh\u00e7et\u2019s syndrome","volume":"53","author":"Moll","year":"1974","journal-title":"Medicine"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"992","DOI":"10.12998\/wjcc.v10.i3.992","article-title":"Occurrence of human leukocyte antigen B51-related ankylosing spondylitis in a family: Two case reports","volume":"10","author":"Lim","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"ref_37","first-page":"112","article-title":"Coexistence of Beh\u00e7et\u2019s disease and ankylosing spondylitis","volume":"10","author":"Karahan","year":"2013","journal-title":"Eur. J. Gen. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s002960000052","article-title":"The coexistence of Beh\u00e7et\u2019s disease and ankylosing spondylitis","volume":"19","author":"Borman","year":"2000","journal-title":"Rheu-matol. Int."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Bischoff, E., Vladeva, S., Bischoff, F., and Kirilov, N. (2026). The Role of HLA-B Typing in Beh\u00e7et\u2019s Disease and Spondyloarthritis: Genetic and Clinical Insights. Life, 16.","DOI":"10.3390\/life16030409"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Perazzio, S.F., Allenspach, E.J., Eklund, K.K., Varjosalo, M., Shinohara, M.M., Torgerson, T.R., and Sepp\u00e4nen, M.R.J. (2020). Behcet disease (BD) and BD-like clinical phenotypes: NF-\u03baB pathway in mucosal ulcerating diseases. Scand. J. Immunol., 92.","DOI":"10.1111\/sji.12973"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Ma, X., Wang, X., Zheng, G., Tan, G., Zhou, F., Wei, W., Tian, D., and Yu, H. (2021). Critical Role of Gut Microbiota and Epigenetic Factors in the Pathogenesis of Beh\u00e7et\u2019s Disease. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.719235"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/art.24423","article-title":"Epidemiology and clinical characteristics of Beh\u00e7et\u2019s disease in the US: A population-based study","volume":"61","author":"Calamia","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/1744666X.2016.1205486","article-title":"Behcet\u2019s disease: Epidemiology, clinical manifestations, and diagnosis","volume":"13","author":"Davatchi","year":"2016","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3346\/jkms.2001.16.5.615","article-title":"Epidemiologic and clinical survey of Behcet\u2019s disease in Korea: The first multicenter study","volume":"16","author":"Bang","year":"2001","journal-title":"J. Korean Med. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1346-8138.2005.tb00807.x","article-title":"Psoriasis Arthropathy and HLA-B51: Report of 5 Cases","volume":"32","author":"Yamamoto","year":"2005","journal-title":"J. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Naib, O.K.D., Aribi, M., Idder, A., Chiali, A., Sairi, H., Touitou, I., Lefranc, G., and Barat-Houari, M. (2013). Association Analysis of IL10, TNF-\u03b1, and IL23R-IL12RB2 SNPs with Beh\u00e7et\u2019s Disease Risk in Western Algeria. Front. Immunol., 4.","DOI":"10.3389\/fimmu.2013.00342"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/BOR.0000000000000003","article-title":"Genetics of Beh\u00e7et\u2019s disease: Lessons learned from genomewide association studies","volume":"26","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_48","first-page":"S22","article-title":"Disease activity measures for rheumatoid arthritis","volume":"25","author":"Dougados","year":"2007","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.2008.094870","article-title":"Development of an ASASendorsed disease activity score (ASDAS) in patients with ankylosing spondylitis","volume":"68","author":"Lukas","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): Validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"International Study Group for Beh\u00e7et\u2019s Disease (1990). Criteria for diagnosis of Behcet\u2019s disease. Lancet, 335, 1078\u20131080.","DOI":"10.1016\/0140-6736(90)92643-V"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"International Team for the Revision of the International Criteria for Beh\u00e7et\u2019s Disease (ITR-ICBD) (2014). The International Criteria for Beh\u00e7et\u2019s Disease (ICBD): A collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J. Eur. Acad. Dermatol. Venereol., 28, 338\u2013347.","DOI":"10.1111\/jdv.12107"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: Development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Care Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/9\/3721\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T12:54:50Z","timestamp":1776862490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/9\/3721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":54,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["ijms27093721"],"URL":"https:\/\/doi.org\/10.3390\/ijms27093721","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]}}}